CTC (Chicago Trading Company)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20
Closed -$1.53M 163
2025
Q3
$1.53M Sell
20
-5,280
-100% -$3.93M ﹤0.01% 137
2025
Q2
$4.13M Sell
5,300
-35,200
-87% -$27.4M ﹤0.01% 119
2025
Q1
$33.4M Buy
40,500
+24,600
+155% +$20.5M 0.02% 87
2024
Q4
$12.3M Buy
15,900
+15,646
+6,160% +$13M 0.01% 125
2024
Q3
$22.5M Sell
254
-216
-46% -$194K 0.01% 112
2024
Q2
$42.6M Buy
470
+95
+25% +$76K 0.02% 102
2024
Q1
$29.2M Buy
+375
New +$267K 0.02% 146

Other funds holding LLY

CTC (Chicago Trading Company)'s LLY Position: Q4 2025 in Review

CTC (Chicago Trading Company) sold out of Eli Lilly (LLY) in Q4 2025, closing a stake of 461 shares — an estimated $441K sold.

CTC (Chicago Trading Company) first reported a position in LLY in Q1 2024 and held it in 6 quarters. The position peaked at $13.6M in Q2 2024. 4,430 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • CTC (Chicago Trading Company) reported no remaining Eli Lilly position as of Q4 2025 after selling out during the quarter.
  • CTC (Chicago Trading Company) sold 461 Eli Lilly shares in Q4 2025, an estimated $441K.
  • CTC (Chicago Trading Company) first reported a position in Eli Lilly in Q1 2024 and held it in 6 quarters.
  • CTC (Chicago Trading Company)'s Eli Lilly position peaked at $13.6M in Q2 2024.
  • 4,430 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on CTC (Chicago Trading Company)'s 13F filing for Q4 2025, filed 18 Feb 2026.